Adaptimmune Therapeutics plc (ADAP) |
|
4.52 0.03 (0.67%)
|
01-17 16:00 |
|
Open: |
4.51 |
Pre. Close: |
4.49 |
|
High:
|
4.82 |
Low:
|
4.3 |
|
Volume:
|
1,885,690 |
Market Cap:
|
475M |
|
|
|
|
Adaptimmune Therapeutics PLC along with its subsidiaries is a clinical-stage biopharmaceutical company. It is engaged in novel cancer immunotherapy products based on its T-cell receptor platform. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
4.823 - 4.837 |
4.837 - 4.853 |
|
Low:
|
4.26 - 4.276 |
4.276 - 4.294 |
|
Close:
|
4.491 - 4.516 |
4.516 - 4.544 |
|
Technical analysis |
as of: 2020-01-17 4:33:38 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 7.01 One year: 8.19 |
| Support: |
Support1: 3.00  Support2: 1.15 |
| Resistance: |
Resistance1: 6.00 Resistance2: 7.01 |
| Pivot: |
2.27 |
| Moving Average: |
MA(5): 4.30 MA(20): 2.04
MA(100): 1.39 MA(250): 2.85  |
| MACD: |
MACD(12,26): 0.79 Signal(9): 0.43 |
| Stochastic oscillator: |
%K(14,3): 68.73 %D(3): 65.61 |
| RSI: |
RSI(14): 93.05 |
| 52-week: |
High: 6.00 Low: 0.71 Change(%): -0.2 |
| Average Vol(K): |
3-Month: 183654 10-Days: 890211 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.ADAP has closed below upper band by 10.9%. Bollinger Bands are 734.1% wider than normal. The large width of the bands suggest high volatility as compared to ADAP's normal range. The bands have been in this wide range for 4 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
2020-01-15
The Daily Biotech Pulse: Nektar Withdraws Opioid Pain Drug NDA, Galapagos Takes Stake In Fibrocor, Integra Lifesciences Lowers Q4 Guidance
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Jan. 14.) Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ): announced an oncology stem cell therapy pact with Astellas Pharma Inc. (OTC: ALPMY ). Applied Therapeutics Inc (NASDAQ: APLT ) Arvinas Inc (NASDAQ: ARVN ) AtriCure Inc. (NASDAQ: ATRC ) AVITA MED LTD/S ADR (NASDAQ: RCEL ) Biondvax Pharmaceuticals Ltd – ADR (NASDAQ: BVXV ) Calithera Biosciences Inc (NASDAQ: CALA ) Editas Medicine Inc (NASDAQ: EDIT ) Eli Lilly And Co (NYSE: LLY ) Epizyme Inc (NASDAQ: EPZM ) Fate Therapeutics Inc (NASDAQ: FATE ) Frequency Therapeutics Inc (NASDAQ: FREQ ) Halozyme Therapeutics, Inc. (NASDAQ: HALO ) (provided 2020 guidance) Hologic, Inc. (NASDAQ: HOLX ) Medpace Holdings Inc (NASDAQ: MEDP ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Myokardia Inc (NASDAQ: MYOK ) NeoGenomics, Inc. (NASDAQ: NEO ) Novo Nordisk A/S (NYSE: NVO ) NuVasive, Inc. (NASDAQ: NUVA ) Profound Medical Corp (NASDAQ: PROF ) Repligen Corporation (NASDAQ: RGEN ) Replimune Group Inc (NASDAQ: REPL ) Revance Therapeutics Inc (NASDAQ: RVNC ) Syneos Health, Inc. (NASDAQ: SYNH ) TG Therapeutics Inc common stock (NASDAQ: TGTX ) Varian Medical Systems, Inc. (NYSE: VAR ) Viela Bio Inc (NASDAQ: VIE ) West Pharmaceutical Services Inc. (NYSE: WST ) XBiotech Inc (NASDAQ: XBIT ) (announced a tender offer to buy up to $420 million worth …
2020-01-13
Adaptimmune Soars 250% On Positive Initial Responses For T-Cell Platform In 4 Tumor Types
Shares of smid-cap biotech Adaptimmune Therapeutics PLC – ADR (NASDAQ: ADAP ) were skyrocketing Monday following a presentation at the 38t
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
